Hadlima

Active Ingredient(s): Adalimumab-bwwd
FDA Approved: * July 23, 2019
Pharm Company: * SAMSUNG BIOEPIS CO LTD
Category: Immunosuppressive

Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5] Common side effects include upper respiratory tract infections, pain at the site o... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hadlima 40 mg/.4ml Subcutaneous Solution
NDC: 50090-6704
Labeler:
A-s Medication Solutions
Hadlima 40 mg/.8ml Subcutaneous Solution
NDC: 50090-6705
Labeler:
A-s Medication Solutions
Hadlima 40 mg/.8ml Subcutaneous Solution
NDC: 50090-6706
Labeler:
A-s Medication Solutions
Hadlima 40 mg/.4ml Subcutaneous Solution
NDC: 50090-6707
Labeler:
A-s Medication Solutions
Hadlima 40 mg/.8ml Subcutaneous Solution
NDC: 78206-183
Labeler:
Organon LLC
Hadlima 40 mg/.8ml Subcutaneous Solution
NDC: 78206-184
Labeler:
Organon LLC
Hadlima 40 mg/.8ml Subcutaneous Solution
NDC: 78206-185
Labeler:
Organon LLC
Hadlima 40 mg/.4ml Subcutaneous Solution
NDC: 78206-186
Labeler:
Organon LLC
Hadlima 40 mg/.4ml Subcutaneous Solution
NDC: 78206-187
Labeler:
Organon LLC

Related Brands

Drugs with the same active ingredients